|
|
|
|
|
|
By Leila Cupersmith, Choice ClinOps | Cell and gene therapy (CGT) has already changed oncology and rare disease care. The next challenge is translating scientific possibilities into credible evidence — and translating approved therapies into financially sustainable patient access. | |
|
|
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
| Connect With Cell & Gene: |
|
|
|